High Point Advisor Group LLC Abb Vie Inc. Transaction History

High Point Advisor Group LLC

$1.76 Billion
Q2 2024

A detailed history of High Point Advisor Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 178,413 shares of ABBV stock, worth $34.8 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

178,413

Previous 176,363 1.16%

Holding current value

$34.8 Million

Previous $32.1 Million 4.71%

% of portfolio

1.74%

Previous 2.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $317,319 - $370,558	2,050 Added 1.16%	178,413 $30.6 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $41,872 - $47,710	262 Added 0.15%	176,363 $32.1 Million
Q4 2023 Mar 26, 2024	BUY	$137.6 - $154.97 $1.56 Million - $1.76 Million	11,358 Added 6.89%	176,101 $27.3 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $1.29 Million - $1.64 Million	-9,366 Reduced 5.38%	164,743 $25.1 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $302,176 - $343,015	2,840 Added 1.66%	174,109 $18.8 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $75,961 - $84,625	722 Added 0.42%	171,269 $19.3 Million
Q1 2021 Apr 12, 2021	SELL	$102.3 - $112.62 $2.49 Million - $2.74 Million	-24,362 Reduced 12.5%	170,547 $18.3 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $7 Million - $9.45 Million	86,948 Added 80.54%	194,909 $20.5 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $934,013 - $1.1 Million	10,872 Added 11.2%	107,961 $10.1 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $326,936 - $437,490	4,456 Added 4.81%	97,089 $9.63 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $5.48 Million - $8.3 Million	84,890 Added 1096.35%	92,633 $7.74 Million
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $5.29 Million - $8.03 Million	-82,084 Reduced 91.38%	7,743 $92.6 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $760,610 - $951,686	10,545 Added 13.3%	89,827 $7.9 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $461,328 - $554,649	7,325 Added 10.18%	79,282 $6.76 Million
Q2 2019 Aug 15, 2019	SELL	$65.7 - $83.98 $42,639 - $54,503	-649 Reduced 0.89%	71,957 $4.89 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $463,688 - $545,738	6,011 Added 9.03%	72,606 $5.66 Million
Q4 2018 Feb 20, 2019	BUY	$77.85 - $96.01 $105,798 - $130,477	1,359 Added 2.08%	66,595 $5.36 Million
Q3 2018 Oct 24, 2018	SELL	$88.91 - $98.84 $114,604 - $127,404	-1,289 Reduced 1.94%	65,236 $5.5 Million
Q2 2018 Aug 20, 2018	SELL	$89.78 - $106.23 $113,033 - $133,743	-1,259 Reduced 1.86%	66,525 $6.53 Million
Q1 2018 Jun 11, 2018	BUY	$92.01 - $123.21 $1.95 Million - $2.6 Million	21,140 Added 45.32%	67,784 $6.81 Million
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $83,201 - $91,237	-929 Reduced 1.95%	46,644 $5.22 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $3.32 Million - $4.24 Million	47,573	47,573 $4.33 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Abb Vie Inc. Transaction History